Springhill Fund Asset Management (Hk) CO LTD Regeneron Pharmaceuticals, Inc. Transaction History
Springhill Fund Asset Management (Hk) CO LTD
- $20.9 Billion
- Q1 2025
A detailed history of Springhill Fund Asset Management (Hk) CO LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Springhill Fund Asset Management (Hk) CO LTD holds 2,600 shares of REGN stock, worth $1.28 Million. This represents 7.9% of its overall portfolio holdings.
Number of Shares
2,600Holding current value
$1.28 Million% of portfolio
7.9%Shares
1 transactions
Others Institutions Holding REGN
# of Institutions
1,471Shares Held
85.8MCall Options Held
1.39MPut Options Held
1.45M-
Vanguard Group Inc Valley Forge, PA9.41MShares$4.62 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$4.15 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY5.66MShares$2.78 Billion0.28% of portfolio
-
State Street Corp Boston, MA4.79MShares$2.35 Billion0.13% of portfolio
-
Capital International Investors Los Angeles, CA3.99MShares$1.96 Billion0.52% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $52.6B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...